IgLON5-mediated neurodegeneration is a differential diagnosis of CNS Whipple disease

Neurology. 2018 Jun 12;90(24):1113-1115. doi: 10.1212/WNL.0000000000005679. Epub 2018 May 16.

¹ From the Movement Disorders Unit, Neurology Department (H.M.-B., B.C., A.F.F., V.F.), Department of Immunology (M.-W.L., J.J.), and Department of Tissue Pathology and Diagnostic Oncology, ICPMR (W.V.), Westmead Hospital; Woolcock Institute of Medical Research (D.B., R.G.), Sydney Medical School (H.M.-B., A.F.F., V.F.), the University of Sydney; Douglass Hanly Moir Pathology (M.R.), New South Wales; and Neuroscience Research Australia (C.S.), Sydney, Australia.
² From the Movement Disorders Unit, Neurology Department (H.M.-B., B.C., A.F.F., V.F.), Department of Immunology (M.-W.L., J.J.), and Department of Tissue Pathology and Diagnostic Oncology, ICPMR (W.V.), Westmead Hospital; Woolcock Institute of Medical Research (D.B., R.G.), Sydney Medical School (H.M.-B., A.F.F., V.F.), the University of Sydney; Douglass Hanly Moir Pathology (M.R.), New South Wales; and Neuroscience Research Australia (C.S.), Sydney, Australia. [email protected].

No abstract available

Publication types